Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Vidhya Priya, P.
- An Endemic Challenge of Dengue - a Crucial Review
Abstract Views :606 |
PDF Views:429
Authors
Vaikundam Kannabirran
1,
Subramanian Madhu
2,
P. Vidhya Priya
3,
R. Uthaya
3,
Senguttuvan Sivan Mozhi
3
Affiliations
1 Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, IN
2 Kamalaktchi Pandurangan College of Pharmacy, Thiruvannamalai, Tamilnadu, IN
3 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry, IN
1 Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, IN
2 Kamalaktchi Pandurangan College of Pharmacy, Thiruvannamalai, Tamilnadu, IN
3 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry, IN
Source
Indian Journal of Drugs and Diseases, Vol 1, No 3 (2012), Pagination: 51-58Abstract
Dengue fever is a serious threat to global health issues; it leads us to a public health challenge with an economic saddle. Approximately 100 countries are endemic for dengue fever and 40% of the world's population or about 2.5 billion people in the tropical and sub-tropics have an increased risk. It is also known break bone fever, is a selflimited, systematic viral infection transmitted from mosquitoes to humans.. Symptoms include fever, headache, muscle and joint pains, and with a characteristic skin rashes that is similar to measles. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome. To the core of this review are ought to discuss about the symptoms, mechanism of the virus in the host, penetration towards our body, characteristic antibody responses, life cycle, various phases involved in the cycle, efficient vector control strategies, pathogenesis, Diagnosis, ongoing therapies, and its management and prevention.Keywords
Aedes aegypti, Systematic Viral Infection, Denv-1, Denv-2, Denv- 3, and Denv-4, Symptoms, Nonstructural (NS) EnzymeReferences
- Barban V, Girerd Y, Mantel M, Aguirre M, Petiard F, Colombani S et al. (2006) Replication and temperature-sensitivity profiles on Vero, Huh-7 and HepG2 cells, of different wild-type compared to either Dengue virus attenuated strains, or chimeric YF viruses presenting Dengue envelope. Abstract: No: 458. 55th ASTMH meeting Atlanta.
- Dengue Fever (2010) Dengue Fever Symptoms denguefeversymptoms.org. Available:http://www.denguefeversymptoms.org/
- Dengue guidelines for diagnosis, treatment, prevention and control. World Health Organization TDR for research on diseases of proverty, New Edn. 2009.
- Guidelines for the treatment of dengue Fever/dengue haemorrhagic fever in small hospital (1999) World health organization regional office for South East Asia New delhi.
- Hanley KA, Vollmer DM and Case TJ (1995) The distribution and prevalence of helminths, coccidia and blood parasites in two competing species of gecko: implications for apparent competition. Oecologia 1995, 102:220-229.
- Joshua Fink et al. (2007) Host gene expression profiling of dengue virus infectionin cell lines and patients. PLoS Neglected Tropical Diseases. www.plosntds.org. 1(2), e86.
- Klawikkan N et al. (2011) Effect of Thai medicinal plant extracts against dengue virus in vitro. Mahidol University J. harmaceutical Sci. pp: 13-18.
- Lindsey NP, Kuhn S, Campbell GL and Hayes EB (2008) Neuroinvasive disease incidence in the United States, 2002–2006. Vector-Borne Zoonotic Dis. 8(1), 35-39.
- Nisar Ahmad et al (2011) Dengue fever treatment with Carica papaya leaves extracts. Asian Pacific J. Tropical Biomedicine. pp: 330-333.
- Nisar Ahmad et al (2011) Dengue fever treatment with Carica papaya leaves extracts. Asian Pacific J. Tropical Biomedicine. pp: 330-333.
- Palmer DR, Fernandez S, Bisbing J, Peachman KK, Rao M, Barvir D, Gunther V, Burgess T, Kohno, Y, Padmanabhan R, Sun W (2007) Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells. J. Gen. Virol. 88 (Pt 1), 148-156.
- Pepin KM and Hanley KA (2008) Density-dependent competitive suppression of sylvatic dengue virus by endemic dengue virus in cultured mosquito cells. Vector Borne Zoonotic Dis. pp: 69-73.
- Sadon N, Delers A, Jarman RG, Klungthong C, Nisalak A, Gibbons RV, Vassilev V (2008) A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples. J. Virol. Methods 153 (1), 1- 6.
- Samuel CE (2001) Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (4), m778–809.
- Shivendra Kumar and et al. (2012) Molecular herbal inhibitor for dengue virus. Int.J.Med.Arom. Plants. 2(1), 1-21.
- Shivendra Kumar et al. (2012) Molecular herbal inhibitor for dengue virus. Int.J.Med.Arom. Plants. 2(1), 1-21.
- Suchitra Nimmannitya (1997) Dengue haemorrhagic fever: diagnosis and management, In: Dengue and Dengue Haemorrhagic Fever edited by Gubler DJ and Kuno G, Published by CAB International, pp: 133-145.
- Suchitra Nimmannitya (1997) Management of DF/DHF in WHO Regional Publication No. 22 – Monograph on Dengue/ DHF– pp: 55-61, WHO/SEARO, New Delhi.
- Suchitra Nimmannitya (1999) Clinical manifestations of DF/DHF in WHO regional publication no. 22 -monograph on dengue/DHF – pp: 48-54, WHO/SEARO, New Delhi.
- Syarifuddin Idrus et al (2012) Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase. Bioinformation. 8(8), 348-352.
- Syarifuddin Idrus et al. (2012) Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase. Bioinformation. 8(8), 348-352.
- Twiddy SS and Holmes EC (2003) The extent of homologous recombination in members of the genus Flavivirus. J. Gen. Virol. 84(2), 429-440.
- Twiddy SS, Farrar JJ, Chau NV, Wills B, Gould EA, Gritsun T, Lloyd G and Holmes EC (2002) Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology. 298, 63-72.
- Wati S, Li P, Burrell CJ and Carr JM (2007) Dengue virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-alpha) and DV infection induces altered responsiveness to TNF-alpha stimulation. J. Virol. 81, 10161-10171.
- Wati S, Rawlinson SM, Ivanov RA, Dorstyn L, Beard MR, Jans DA, Pitson SM, Burrell CJ, Li P and Carr JM (2011) Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-{alpha} to activate nuclear factor {kappa} B and reduced sphingosine kinase-1 activity. J. Gen. Virol. 92,807- 818.
- World Health Organization (2002) Fact sheet No. 117, Geneva: WHO.
- World Health, Organization, 1997. Dengue Haemorraghic Fever: Diagnosis, treatment prevention and control, 2nd ed. World Health Organization, Geneva, Switzerland.
- Zuckerkandl E and Pauling L (1965) Molecules as documents of evolutionary history.J. Theor. Biol. 8, 357-366.
- A Lethal Switch "the Dengue - an Inclusive Review"
Abstract Views :531 |
PDF Views:458
Authors
R. Uthaya
1,
Vaikumdam Kannabirran
2,
Subramanian Madhu
,
Senguttuvan Sivan Mozhi
3,
P. Vidhya Priya
3
Affiliations
1 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu
2 Kamalaktchi Pandurangan College of Pharmacy, Thiruvannamalai, Tamilnadu, IN
3 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, IN
1 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu
2 Kamalaktchi Pandurangan College of Pharmacy, Thiruvannamalai, Tamilnadu, IN
3 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, IN
Source
Indian Journal of Drugs and Diseases, Vol 1, No 3 (2012), Pagination: 79-91Abstract
Dengue fever also known as break bone fever, is a self limited, systematic viral infection transmitted between humans by mosquitoes. It leads to a public health challenge with an economic saddle. Its symptoms include fever, headache, muscle and joint pains, and a characteristic skin rash that is similar to measles. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs. Dengue fever is a serious threat to global health issues. Approximately 100 countries are endemic for dengue fever and 40% of the world's population or about 2.5 billion people in the tropical and sub-tropics have an increased risk of catching the disease. So, to the core of the review we are ought to discuss about a wide topics towards the symptoms, Mechanism of the virus in the host, penetration towards our body, Characteristic antibody responses, life cycle, various phases involved in the cycle, efficient vector control strategies, pathogenesis, Diagnosis, ongoing therapies, and its management and prevention. In addition, we ought to suggest at conclusion that would be a better way to research in this type of disease with reviews.Keywords
Break Bone Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome, Flavivirus VectorsReferences
- Ackermann M and Padmanabhan R (2001) De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J. Biol. Chem. 276 (43), 39926–39937.
- Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J and Schols D (2009) Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology. 387, 67-75.
- Ananda Rao R, Swaminathan S, Fernando S, Jana AM and Khanna N (2005) A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent. Protein Exp. Purif. 41, 136-147.
- Atrasheuskaya A, Petzelbauer P, Fredeking TM and Ignatyev G (2003) Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 35 (1), 33-42.
- Blaney Jr JE, Sathe NS, Goddard L, Hanson CT, Romero TA, Hanley KA, et al(2008) Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4. Vaccine. 26(6), 817-828.
- Bruno Guy et al (2010) Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses evaluation of Chimeri Vax-based vaccines, Vaccine 28, 632 – 649.
- Cangel PY, Chan et al (2006) Detection of serum neopterin for early assessment of dengue virus infection. J. Infection, 53, 152, e158. dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res. 57, 63-79.
- Fried JR, Gibbons RV, Kalayanarooj S et al. (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl. Trop. Dis. 4, e617.
- Helle Bielefeldt-Ohmann (1998) Analysis of antibody-independent binding of dengue viruses and
- Huan-Yao Lei et al (2001) Immunopathogenesis of Dengue Virus Infection. J. Biomed. Sci. 8,377-388.
- Melino S and Paci M (2007) Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach. FEBS J. 274, 2986–3002.
- Michelle Meyer et al (2000) Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res. 73, 81-89.
- Mishra KP et al (2012) Dengue virus infection induces upregulation of hn RNP-H and PDIA3 for its multiplication in the host cell. Virus Res. 163, 573-579.
- Osmali Osmana et al (2008) Complete genome sequence analysis of dengue virus type 2 isolated in Brunei. Virus Res. 135 (2008) 48–52.
- Ratree Takhampunya et al (2009) Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon. signalling ability. Virus Res. 145, 31-38.
- Ravulapalli AnandaRao et al (2005) The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides. Virus Res. 112, 60-68.
- Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM and da Rosa AT (1997) Origins of dengue type 2 Viruses associated with increased pathogenicity in the Americas. Virology. 230(2), 244-251.
- Rossi SL et al (2012) Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology .423, 58-67.
- Sabin AB (1952) Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1(1), 30-50.
- Salvador Chavez-Salinas et al (2008) Heat shock effect upon dengue virus replication into U937 cells. Virus Res. 138, 111-118.